[1] |
Simons FE, Simons KJ. Histamine and H1⁃antihistamines: celebrating a century of progress[J]. J Allergy Clin Immunol, 2011, 128(6): 1139⁃1150.e4. DOI: 10.1016/j.jaci.2011.09.005.
|
[2] |
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update[J]. Allergy, 2014, 69(7): 868⁃887. DOI: 10.1111/all.12313.
|
[3] |
中华医学会皮肤性病学分会免疫学组. 中国荨麻疹诊疗指南(2014版)[J]. 中华皮肤科杂志, 2014, 47(7): 514⁃516. DOI: 10.3760/cma.j.issn.0412⁃4030.2014.07.019.
|
[4] |
Sharma M, Bennett C, Carter B, et al. H1⁃antihistamines for chronic spontaneous urticaria: an abridged cochrane systematic review[J]. J Am Acad Dermatol, 2015, 73(4): 710⁃716.e4. DOI: 10.1016/j.jaad.2015.06.048.
|
[5] |
Takahashi H, Kaneko S, Chinuki Y, et al. Clinical efficacy of loratadine for chronic urticaria refractory to other antihistamines[J]. Nishi Nihon Hifuka, 2012, 74(3): 293⁃300. DOI: 10.2336/nishinihonhifu.74.293.
|
[6] |
Yamanaka K, Motomura E, Noro Y, et al. Olopatadine, a non⁃sedating H1 antihistamine, decreases the nocturnal scratching without affecting sleep quality in atopic dermatitis[J]. Exp Dermatol, 2015, 24(3): 227⁃229. DOI: 10.1111/exd.12630.
|
[7] |
Hossen MA, Fujii Y, Ogawa M, et al. Effect of loratadine on mouse models of atopic dermatitis associated pruritus[J]. Int Immunopharmacol, 2005, 5(7⁃8): 1331⁃1336. DOI: 10.1016/j.intimp.2005.02.004.
|
[8] |
中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心. 中国特应性皮炎诊疗指南(2014版)[J].中华皮肤科杂志, 2014, 47(7): 511⁃514. DOI: 10.3760/cma.j.issn.0412⁃4030.2014.07.018.
|
[9] |
中华医学会皮肤性病学分会免疫学组. 湿疹诊疗指南(2011年)[J].中华皮肤科杂志, 2011, 44(1): 5⁃6. DOI: 10.3760/cma.j.issn.0412⁃4030.2011.01.002.
|
[10] |
O′Donoghue M, Tharp MD. Antihistamines and their role as antipruritics[J]. Dermatol Ther, 2005, 18(4): 333⁃340. DOI: 10.1111/j.1529⁃8019.2005.00034.x.
|
[11] |
Paul E. Treatment of pruritic skin diseases with loratadine. Results of an open multicenter study[J]. Fortschr Med, 1991, 109(7): 175⁃178.
|
[12] |
Simons FE. Prospective, long⁃term safety evaluation of the H1⁃receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC study group. early treatment of the atopic child[J]. J Allergy Clin Immunol, 1999, 104(2 Pt 1): 433⁃440.DOI: 10.1016/S0091⁃6749(99)70389⁃1.
|
[13] |
Mann RD, Pearce GL, Dunn N, et al. Sedation with "non⁃sedating" antihistamines: four prescription⁃event monitoring studies in general practice[J]. BMJ, 2000, 320(7243): 1184⁃1186. DOI: 10.1136/bmj.320.7243.1184.
|
[14] |
Affrime MB, Brannan MD, Lorber RR, et al. A 3⁃month evaluation of electrocardiographic effects of loratadine in healthy individuals[J]. Adv Ther, 1999, 16(4): 149⁃157.
|
[15] |
Simons FE, Silas P, Portnoy JM, et al. Safety of cetirizine in infants 6 to 11 months of age: a randomized, double⁃blind, placebo⁃controlled study[J]. J Allergy Clin Immunol, 2003, 111(6): 1244⁃1248. DOI: 10.1067/mai.2003.1496.
|
[16] |
Grimfeld A, Holgate ST, Canonica GW, et al. Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study[J]. Clin Exp Allergy, 2004, 34(11): 1665⁃1672. DOI: 10.1111/j.1365⁃2222.2004.02098.x.
|